Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome.

MLA

Beta, Anastasia, et al. “Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome.” International Urogynecology Journal, vol. 35, no. 6, June 2024, pp. 1317–22. EBSCOhost, https://doi.org/10.1007/s00192-024-05809-0.

APA

Beta, A., Giannouli, A., Rizos, D., Mantzou, A., Deligeoroglou, E., & Bakas, P. (2024). Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome. International Urogynecology Journal, 35(6), 1317–1322. https://doi.org/10.1007/s00192-024-05809-0

Chicago

Beta, Anastasia, Aikaterini Giannouli, Demetrios Rizos, Aimilia Mantzou, Efthymios Deligeoroglou, and Panagiotis Bakas. 2024. “Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome.” International Urogynecology Journal 35 (6): 1317–22. doi:10.1007/s00192-024-05809-0.